LondonDZ-ART1 fuses a malaria drug to tumor-homing dye.
Pancreatic cancer has among the worst five-year survival of any common tumor.
The compound accumulates 5-10 times more in cancer cells, disrupting mitochondria to starve them of energy, trials found.
The manuscript is unedited, and no human trial has yet been reported.
Sources: Nature